(10), having lycopodine-related structures, were isolated from the club moss Lycopodium serratum THUNB. and their structures were elucidated on the basis of spectroscopic analysis and/or chemical transformation.
Lycopodium alkaloids [1] [2] [3] isolated from club mosses of the genus Lycopodium (Lycopodiaceae) exhibit fascinating complex structures and have attracted the attention of synthetic organic chemists [4] [5] [6] [7] [8] [9] [10] as well as pharmacologists because of such potent biological activities as an inhibitory effect on acetylcholinesterase. 11) Recent extensive studies on the chemical constituents in Lycopodium plants have resulted in the isolation of a number of new alkaloids having novel and diverse structures. [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] Recently, we have also isolated several new alkaloids having fawcettimine-related structures from Lycopodium serratum THUNB. [27] [28] [29] In our continuing investigation of the structurally unique Lycopodium alkaloids from this plant, we have purified and identified ten new alkaloids possessing lycopodine-related skeletons. We report herein the structure elucidation of those alkaloids.
The crude basic fraction obtained by a conventional procedure from the MeOH extract of the club moss L. serratum collected in Boso Peninsula, Japan, was purified by repeated chromatography over SiO 2 to afford new alkaloids, lycoposerramines-F (1, 0.03% based on the crude base), -G (2, 0.13%), -H (3, 0.29%), -I (4, 0.14%), -J (5, 0.08%), -K (6, 0.05%), -L (7, 0.10%), -M (8, 0.10%), -N (9, 0.03%), and -O (10, 0.06%), along with known alkaloids belonging to the lycopodine group, i.e., lycopodine, 30) lucidioline (11) , 31) L.20 (12) , 15, 32, 33) lycodoline, 15, 24, 30, 34) deacetyllycoclavine (15) , 35, 36) acetyllycoclavine (17) , 37) serratidine, 38) and serratezomine C. 15) Compound 1, named lycoposerramine-F, was obtained as colorless prisms (mp Ͼ300°C). High-resolution fast atom bombardment mass spectrometry (HR-FAB-MS) analysis gave m/z 296.1848 (MϩH) ϩ (D Ϫ1.4 mmu) and established the molecular formula as C 16 H 25 NO 4 . IR absorption implied the presence of hydroxyl (3403 cm
Ϫ1
) and ketone (1713 cm Ϫ1 ) groups.
1 H-and 13 C-NMR spectra (see Table 1 ) as well as distorsionless enhancement by polarization transfer (DEPT) spectra suggested the presence of one ketone, two sp 3 quaternary carbons having an oxygen function, one sp 3 quaternary carbon, two sp 3 methines, nine sp 3 methylenes, and one methyl group. 1 H-1 H correlation spectroscopy (COSY) and 1 H-detected heteronuclear multiple quantum coherence (HMQC) spectra indicated the presence of the following three fragments: -CH 2 CH 2 CH 2 -(C1-C3), -CH 2 CH 2 CH 2 -(C9-C11), and -CH 2 CHCH 2 CH(CH 3 )CH 2 -(C6-C8-C15(C16)-C14), as shown by a bold line in Fig. 1 .
1 H-Detected heteronuclear multiple bond connectivity (HMBC) correlations between the protons (d 2.14, 3.24, H-6) at the terminal carbon (C-6) and the carbonyl carbon (C-5, d 207.3) as well as an oxygenated quaternary carbon (C-4, d 73.6) indicated the presence of an a-hydroxyketone residue. Further, HMBC correlations between the protons at the same terminal carbon (C-6) and the other oxygenated quaternary carbon (C-12, d 78.9) and between the protons (d 2.62, 1.84, H-14) at the other terminal carbon (C-14) and a quaternary carbon (C-13), C-4 and C-12 indicated the presence of a bicyclo[3.3.1]nonane system including a ketone and two tertiary hydroxyl groups. HMBC correlations between the protons (d 2.93, 3.52, H-1) at the methylene carbon (C-1) bearing a nitrogen and a methylene carbon (C-9, d 64.9) as well as a quaternary carbon (C-13, d 75.0) indicated that these three carbons were connected by a nitrogen atom. All of these data indicated that 1 had lycopodane skeleton. The molecular formula and the 13 C chemical shifts of the nitrogen bearing carbons (C-1, C-9, C-13) implied that 1 existed as an N-oxide. The structure inferred by spectroscopic analysis was confirmed by X-ray crystallographic analysis (Fig. 2) . To the best our knowledge, this is the first example of a lycopodinetype alkaloid existing as an N-oxide in nature. NO 3 , which was one oxygen atom less than 1 described above. The 1 H-and 13 C-NMR (Table 1 ) spectra of 2, which resembled those of 1 except for the chemical shifts of the carbons adjacent to nitrogen, indicated that 1 was an N-oxide derivative of 2. Actually, when 2 was treated with one equivalent of m-CPBA, lycoposerramine-F (1) was obtained in 63% yield, thereby establishing the structure of the new alkaloid as formula 2.
Ten New Lycopodium Alkaloids
Lycoposerramine-H (3) was obtained as colorless prisms (mp 227-228°C, sublimation). HR-FAB-MS analysis gave m/z 262.1809 (MϩH) ϩ (D ϩ0.2 mmu) and established the molecular formula as C 16 H 23 NO 2 , which indicated that 3 had one extra unsaturated number compared to common lycopodine-type alkaloids.
1 H-and 13 C-NMR spectra (see Table 1 ) as well as DEPT spectra suggested the presence of one ketone, a trisubstituted olefin bearing a methyl group, one sp . The structure including the stereochemistry of the secondary hydroxyl group at C-6 was determined by X-ray analysis as formula 3 (Fig. 3) . This is the first example of a lycopodine-type alkaloid that has a double bond at the C-8-C-15 position.
Lycoposerramine-I (4) showed a molecular ion peak at m/z 261 and the molecular formula, C 16 Table 1 ) with those of 3 suggested that the two alkaloids were isomers at the position of the secondary hydroxyl group. The chemical shifts at C-10 (d 35.5), C-11 (d 69.2), and C-12 (d 44.6) in 4 as well as the HMBC cross-peak (Fig. 4) between the low-field proton (d 4.34) and the quaternary carbon at C-13 (d 59.7) indicated that the hydroxyl group existed at the C-11 position. The stereochemistry of the hydroxyl group at this position was deduced to be a-axial orientation based on the coupling constants (ddd, Jϭ2.8, 2.8, 2.8 Hz) (Fig. 4) of the proton at C-11. Vol. 51, No. 10 Lycoposerramine-J (5) 13 C-NMR spectrum did not show any signals ascribable to the carbonyl function. Instead, two methine carbons (d 73.1, 77.5) bearing an oxygen function were observed, indicating that the carbonyl, which was commonly present at C-5 in lycopodine alkaloids, was displaced by a hydroxyl function in the new alkaloid 5. Actually, when 3 was reduced with NaBH 4 in MeOH, 5 was obtained in quantitative yield as the sole product. (Fig. 4) The stereochemistry of the secondary hydroxyl group at C5 was deduced to be b-axial configuration based on observations of the W-configuration long-range coupling between H-5 and H-7 as well as the previously reported fact 37, 39) that the reduction of the carbonyl group at C-5 in the lycopodine group occurred diastereoselectively from the a face.
Lycoposerramine-K (6) showed a pseudomolecular ion peak at m/z 262 and the molecular formula, C 16 (Fig. 4) and by comparing the 13 C chemical shifts (see Table  1 ) with those of lucidioline (11), 31) a known alkaloid that was simultaneously isolated from this plant. H COSY and HMQC spectra revealed that 7 had the fundamental lycopodane skeleton. The HMBC cross-peak (Fig. 5 ) between the proton (d 4.24) and the carbonyl carbon (C-5) indicated the presence of a hydroxyl group at the C-6 position. From these data, lycoposerramine-L was deduced to be 6-hydroxylycopodine, which corresponded to a known alkaloid, L20, 15, 32, 33) i.e., 6-a-hydroxylycopodine (12) . The 1 Hand 13 C-NMR spectra of 7 and L.20 (12) were very similar with the exception of the chemical shifts at C-6 (d 73.7) and C-8 (d 35.0), suggesting that they were stereoisomers at the C-6 position. The observed NOE between H-6 (d 4.24) and H-4 (d 3.02) revealed that the structure of new alkaloid 7 was 6-b-hydroxylycopodine.
Lycoposerramine-M (8) showed a molecular ion peak at m/z 263 and the molecular formula, C 16 13 C-NMR spectra (Table 1) suggested the presence of sixteen carbons ascribable to the lycopodane framework (vide infra) and two additional ester groups. 1 H-1 H COSY and HMQC spectra indicated the presence of the following three fragments in the alkaloid portion: a, -CH 2 CH 2 CH 2 CHCH-(C1-C5); b, -CH 2 CH 2 CH 2 CH-(C9-C12); and c, -CHCHCH 2 CH(CH 3 )CH 2 -(C6-C8-C15(C16)-C14). Partial units a and c as well as b and c could be connected by the HMBC cross-peaks (H-5/C-6, H-5/C-7, H-6/C-5, H-6/C-4) and (H-14/C-12, H-6/C-12), respectively (Fig. 6 ). These three units could be further linked through the nitrogen atom on the basis of the following HMBC correlations: H-1/C-13, H-9/C-13, H-5/C-13, and H-14/C-13. These data suggested that 10 had the basic lycopodane skeleton; however, the functional group at C-5 was replaced from an ordinary ketone with an ester group, as shown by the H-and 13 C-NMR spectra showed the presence of an ethane fragment, a methoxy group, a phenolic hydroxyl function, and a benzene ring, on which the first three groups were located in a 1,2,4-substitution mode, as inferred from the splitting pattern of the protons on the benzene ring. The positions of these three functions were elucidated from the HMBC correlations as shown in the Fig. 6 , and indicated the presence of a dihydroferulate as the ester structure on C-5. The relative stereochemistries at C-5 and C-6 were deduced from the NOE correlation and by comparing the coupling constants of the corresponding protons with Vol. 51, No. 10 those of a known alkaloid, as follows. Thus, the NOE crosspeak of H-6/H-15 suggested an a-orientation of the acetoxy group at C-6. Further, the coupling constants of the protons at H-5 (d, Jϭ7.0 Hz) and H-6 (broad, s) strongly resembled those of a known alkaloid, acetyllycoclavine (17), 37) indicating the stereochemistry at C-5 was a b-axial configuration. To confirm the structure inferred from the spectroscopic analysis above, we attempted to synthesize 10 from a known alkaloid. Initially, the hydroxyl group in L.20 (12) was acetylated under conventional conditions (Ac 2 O and pyridine) to give the desired acetate (13) 33) in 46% yield together with the enol acetate (14) 33) in 50% yield, which could be converted into 13 by hydrolysis under acidic conditions (1 N HCl, MeOH, rt). The carbonyl function in 13 was reduced with NaBH 4 in MeOH to give the alcohol derivative (16) as the sole product. Partial acetylation (one equivalent of Ac 2 O and excess pyridine in CH 2 Cl 2 ) of the diol in a known alkaloid, deacetyllycoclavine (15) , afforded the same product as that obtained by reduction of 13 above, demonstrating the stereochemistry of the hydroxyl group at C-5 in 16 to be b-orientation. The thus-obtained C-6 monoacetylated compound (16) was subjected to esterification with O-benzyl 3-(4-hydroxy-3-methoxylphenyl)propanoic acid (18), 40) which was prepared from commercially available ferulic acid. Finally, the protecting group on the phenol group was removed by hydrogenolysis to furnish the target compound, which was found to be completely identical with natural 10 by comparison of their chromatographic behavior and spectroscopic data including [a] D . Therefore, the structure of lycoposerramine-O was determined to be formula 10.
C5) was further purified by SiO 2 column chromatography using 3% MeOH in CHCl 3 to afford 9.1 mg of lycoposerramine-H (3) and 1.1 mg of lycoposerramine-N (9). The 20% MeOH in CHCl 3 eluate (fraction C6) was rechromatographed over SiO 2 using 5% MeOH in CHCl 3 to give 3.1 mg of lycoposerramine-L (7) together with 5.5 mg of lycopodine. The 20% MeOH in CHCl 3 -MeOH eluate (fraction C7) was further purified by SiO 2 column chromatography using 10% MeOH in AcOEt to afford 1.3 mg of acetyllycoclavine (17) . The 30% MeOH in CHCl 3 saturated with NH 4 OH eluate (fraction D) was rechromatographed over SiO 2 using 0-20% MeOH in AcOEt to give six fractions (D1-D6). The 5-10% MeOH in AcOEt eluate (fraction D3) was further purified by SiO 2 column chromatography using 5% MeOH in CHCl 3 to afford 4.4 mg of lycoposerramine-I (4), 1.9 mg of lycoposerramine-O (10) together with 21.6 mg of L.20 (12) . The 10-15% MeOH in AcOEt eluate (fraction D4) was purified by SiO 2 using 5% MeOH in CHCl 3 to afford 3.2 mg of lycoposerramine-M (8) 3 The final R value was 0.046 (R w ϭ0.053) for 1750 reflections (IϾ1s(I) ).
Lycoposerramine-G ( m-CPBA Oxidation of Lycoposerramine-G (2) To a stirred solution of 2 (1.8 mg, 0.00645 mmol) in dry CH 2 Cl 2 (0.5 ml) was added m-CPBA (1.5 mg, 0.00669 mmol) at 0°C under argon atmosphere. After the reaction mixture was stirred at 0°C for 2.5 h, it was directly subjected to Al 2 O 3 column chromatography (0-100% MeOH in CHCl 3 ) to give 1.2 mg (yield 63%) of 1. All the spectroscopic data ( 
NaBH 4 Reduction of Lycoposerramine-H (3)
To a stirred solution of 3 (2.9 mg, 0.0111 mmol) in dry MeOH (0.5 ml) was added NaBH 4 (4.9 mg, 0.0544 mmol) at 0°C under argon atmosphere. After the reaction mixture was stirred at 0°C for 9.5 h, it was poured onto ice-cold water and was extracted with CHCl 3 . The combined organic layer was washed with brine, dried over MgSO 4 , and evaporated. The residue was purified by Al 2 O 3 column chromatography (0-5% MeOH in AcOEt) to give 5 (3.0 mg, quantitative yield) as a colorless solid. All the spectroscopic data ( 1 H-, 13 C-NMR, MS and [a] D ) were identical with those of natural 5.
Lycoposerramine-K (6): Colorless amorphous powder; IR (CHCl 3 ) n max 3384 (hydroxyl group), 1714 (ketone) cm 77. 8, 60.6, 47.4, 46.8, 44.0, 42.1, 41.4, 40.4, 38.8, 26.1, 25.9, 25.8, 23.0 
Hydrolysis of Enol Acetate (14)
To a solution of 14 (7.9 mg, 0.0228 mmol) in MeOH (0.28 ml) was added 1 N HCl solution (50 ml) under argon atmosphere. After the reaction mixture was stirred at room temperature for 47.5 h, it was evaporated to dryness. The residue was diluted with chilled sat. NaHCO 3 solution and was extracted with 5% MeOH in CHCl 3 . The combined organic phase was washed with brine, dried over MgSO 4 and evaporated. The residue was separated by SiO 2 column chromatography (13% MeOH in AcOEt) to give 13 (1.9 mg, yield 27%) as an amorphous powder.
Reduction of L.20 Acetate (13) To a solution of 13 (11.5 mg, 0.0337 mmol) in dry EtOH (1.0 ml) was added NaBH 4 (2.6 mg, 0.0687 mmol) at 0°C under argon atmosphere. After the reaction mixture was stirred at 0°C for 8.5 h, it was poured into ice-cold water and was extracted with 5% MeOH in CHCl 3 . The combined organic phase was washed with brine, dried over MgSO 4 Partial Acetylation of Deacetyllycoclavine (15) To a solution of 15 (9.4 mg, 0.0355 mmol) in dry CH 2 Cl 2 (0.5 ml) was added dry Ac 2 O (3.3 ml, 0.0355 mmol) and dry pyridine (28 ml, 0.173 mmol) at 0°C under argon atmosphere. After the reaction mixture was stirred at room temperature for 20.5 h, it was warmed to 40°C and stirred for further 97.5 h. Then the reaction mixture was cooled to room temperature and evaporated to dryness. The residue was poured into chilled sat. NaHCO 3 solution and was extracted with 5% MeOH in CHCl 3 . The combined organic phase was washed with brine, dried over MgSO 4 and evaporated. The residue was separated by SiO 2 column chromatography (0-20% MeOH in CHCl 3 ) to give 16 (1.4 mg, yield 13%) as an amorphous powder.
Preparation of Lycoposerramine-O (10) from 16 To a solution of 16 (2.1 mg, 0.0068 mmol) in dry CH 2 Cl 2 (0.5 ml) was successively added DMAP (2.2 mg, 0.018 mmol), 18 (5.9 mg, 0.0206 mmol), and DCC (4.2 mg, 0.0204 mmol) at room temperature under argon atmosphere. After the reaction mixture was stirred at 40°C for 10 h, it was cooled to room temperature and poured into chilled sat. NaHCO 3 solution and was extracted with 5% MeOH in CHCl 3 . The combined organic phase was dried over MgSO 4 35 H 46 NO 6 576.3325). A solution of the ester (9.4 mg, 0.016 mmol) in dry EtOH (0.5 ml) was hydrogenated in the presence of 10% Pd on carbon (4.6 mg) for 1 h at room temperature. The catalyst was removed by filtration and the solvent was evaporated. The residue was separated by amino silica gel column chromatography (20% Me 2 CO in n-hex) to give 10 (2.6 mg, yield 33%) as an amorphous powder. All the spectroscopic data including 
